Pharma Shares Fall Pre-Bell Following Plan by Trump to Reduce US Prescription Drug Prices

MT Newswires Live05-12

Pfizer (PFE), AstraZeneca (AZN), Johnson & Johnson (JNJ), and other drug company shares fell in Monday's premarket activity after US President Donald Trump vowed to sign an executive order to reduce prescription drug prices for Americans.

"We are going to do the right thing," Trump wrote Sunday on his Truth Social account. "I will be signing one of the most consequential Executive Orders in our Country's history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%."

Novo Nordisk (NVO) shares were down around 3.8% pre-bell, while Pfizer shares were down nearly 3.5%, AstraZeneca shares dropped 2.7%, and Johnson & Johnson declined 2.6%.

Bristol-Myers Squibb (BMY) and Merck (MRK) both fell 2.4%, Eli Lilly (LLY) was down 2.2%, and GSK (GSK) around 2%.

Trump said he will institute a policy whereby the US will pay the same price for prescription drugs as the lowest price anywhere in the world.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2534245266?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-05-12 17:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534245266","market":"sg","top_or_hot":-1,"title":"Pharma Shares Fall Pre-Bell Following Plan by Trump to Reduce US Prescription Drug Prices","media":"MT Newswires Live","content":"<html><body><p> Pfizer (PFE), AstraZeneca (AZN), Johnson &amp; Johnson (JNJ), and other drug company shares fell in Monday's premarket activity after US President Donald Trump vowed to sign an executive order to reduce prescription drug prices for Americans.</p><p>\"We are going to do the right thing,\" Trump wrote Sunday on his Truth Social account. \"I will be signing one of the most consequential Executive Orders in our Country's history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%.\"</p><p>Novo Nordisk (NVO) shares were down around 3.8% pre-bell, while Pfizer shares were down nearly 3.5%, AstraZeneca shares dropped 2.7%, and Johnson &amp; Johnson declined 2.6%.</p><p>Bristol-Myers Squibb (BMY) and Merck (MRK) both fell 2.4%, Eli Lilly (LLY) was down 2.2%, and GSK (GSK) around 2%.</p><p>Trump said he will institute a policy whereby the US will pay the same price for prescription drugs as the lowest price anywhere in the world.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharma Shares Fall Pre-Bell Following Plan by Trump to Reduce US Prescription Drug Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharma Shares Fall Pre-Bell Following Plan by Trump to Reduce US Prescription Drug Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-12 17:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Pfizer (PFE), AstraZeneca (AZN), Johnson &amp; Johnson (JNJ), and other drug company shares fell in Monday's premarket activity after US President Donald Trump vowed to sign an executive order to reduce prescription drug prices for Americans.</p><p>\"We are going to do the right thing,\" Trump wrote Sunday on his Truth Social account. \"I will be signing one of the most consequential Executive Orders in our Country's history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%.\"</p><p>Novo Nordisk (NVO) shares were down around 3.8% pre-bell, while Pfizer shares were down nearly 3.5%, AstraZeneca shares dropped 2.7%, and Johnson &amp; Johnson declined 2.6%.</p><p>Bristol-Myers Squibb (BMY) and Merck (MRK) both fell 2.4%, Eli Lilly (LLY) was down 2.2%, and GSK (GSK) around 2%.</p><p>Trump said he will institute a policy whereby the US will pay the same price for prescription drugs as the lowest price anywhere in the world.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999014567.USD","symbol_name":"UOB UNITED INCOME FOCUS TRUST FUND (USD) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2534245266","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534245266","pubTimestamp":1747043715,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pfizer , AstraZeneca , Johnson & Johnson , and other drug company shares fell in Monday's premarket activity after US President Donald Trump vowed to sign an executive order to reduce prescription drug prices for Americans.\"We are going to do the right thing,\" Trump wrote Sunday on his Truth Social account. \"I will be signing one of the most consequential Executive Orders in our Country's history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%.\"Novo Nordisk  shares were down around 3.8% pre-bell, while Pfizer shares were down nearly 3.5%, AstraZeneca shares dropped 2.7%, and Johnson & Johnson declined 2.6%.Bristol-Myers Squibb  and Merck  both fell 2.4%, Eli Lilly  was down 2.2%, and GSK  around 2%.Trump said he will institute a policy whereby the US will pay the same price for prescription drugs as the lowest price anywhere in the world.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SG9999014567.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USD) ACC","LU0965508806.USD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (USD) INC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","LU0122379950.USD":"贝莱德世界健康科学A2","GSK":"葛兰素史克","BMY":"施贵宝","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","IE00BGHQF631.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) ACC","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","IE0034235303.USD":"PINEBRIDGE US RESEARCH ENHANCED CORE EQUITY \"A\" (USD) ACC","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","BK4599":"减肥药","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4532":"文艺复兴科技持仓","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU2242652126.USD":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) INC","SG9999017495.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"B\" (SGD) ACC","LU1829250122.USD":"高盛欧洲核心股票组合Acc","LU2129689514.USD":"FRANKLIN GLOBAL INCOME \"A\" (USD) INC","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","SG9999014914.USD":"UNITED GLOBAL QUALITY GROWTH (USDHDG) INC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","MRK":"默沙东","LU0094547139.USD":"abrdn SICAV I - GLOBAL SUSTAINABLE EQUITY FUND \"A\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","AZN":"阿斯利康","PFE":"辉瑞","NVO.AU":"NOVO RESOURCES CORP-CDI","LU0237698245.USD":"富达环球地产基金A","LU1670710588.SGD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (SGD) ACC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU1221951046.USD":"NORDEA 1 STABLE RETURN \"HM\" (USDHDG) INC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","PFE.AU":"PANTERA MINERALS LTD","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","GSK.UK":"葛兰素史克","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","JNJ":"强生","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","LU0471298694.HKD":"BGF NUTRITION \"A2\" (HKD) ACC"},"translate_title":"特朗普计划降低美国处方药价格后，盘前制药股下跌","themeId":"c16d71d2eba9cb3da9792d48223abc57","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZN":0.9,"BMY":0.9,"GSK":0.9,"GSK.UK":0.6,"JNJ":0.9,"MRK":0.9,"NVO.AU":1,"PFE":0.9,"PFE.AU":1},"content_text":"Pfizer (PFE), AstraZeneca (AZN), Johnson & Johnson (JNJ), and other drug company shares fell in Monday's premarket activity after US President Donald Trump vowed to sign an executive order to reduce prescription drug prices for Americans.\"We are going to do the right thing,\" Trump wrote Sunday on his Truth Social account. \"I will be signing one of the most consequential Executive Orders in our Country's history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%.\"Novo Nordisk (NVO) shares were down around 3.8% pre-bell, while Pfizer shares were down nearly 3.5%, AstraZeneca shares dropped 2.7%, and Johnson & Johnson declined 2.6%.Bristol-Myers Squibb (BMY) and Merck (MRK) both fell 2.4%, Eli Lilly (LLY) was down 2.2%, and GSK (GSK) around 2%.Trump said he will institute a policy whereby the US will pay the same price for prescription drugs as the lowest price anywhere in the world.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.34.1","shortVersion":"4.34.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2534245266"}